Condition: Osteoarthritis of the Knee · Sponsor: Rush University Medical Center
Prospective single-masked (study participant will be masked), randomized controlled trial to examine the influence of BMAC on patient-reported outcomes (PROs) in patients with primary knee osteoarthritis.
This description comes directly from the study's public registry record.
Carla M. Edwards, PhD · 312-563-5735 · carla_edwards@rush.edu
Jorge Chahla, MD · (312) 432-2818 · jorge.chahla@rushortho.com
Always discuss trial participation with your own doctor first.
| Rush University Medical Center | Chicago, Illinois, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05985785